Cytotoxic Effects of 5-Azacytidine on Primary Tumour Cells and Cancer Stem Cells from Oral Squamous Cell Carcinoma: An In Vitro FTIRM Analysis.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
19 08 2021
Historique:
received: 31 07 2021
revised: 10 08 2021
accepted: 17 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 30 11 2021
Statut: epublish

Résumé

In the present study, the cytotoxic effects of 5-azacytidine on primary Oral Squamous Cell Carcinoma cells (OSCCs) from human biopsies, and on Cancer Stem Cells (CSCs) from the same samples, were investigated by an in vitro Fourier Transform InfraRed Microscospectroscopy (FTIRM) approach coupled with multivariate analysis. OSCC is an aggressive tumoral lesion of the epithelium, accounting for ~90% of all oral cancers. It is usually diagnosed in advanced stages, and this causes a poor prognosis with low success rates of surgical, as well as radiation and chemotherapy treatments. OSCC is frequently characterised by recurrence after chemotherapy and by the development of a refractoriness to some employed drugs, which is probably ascribable to the presence of CSCs niches, responsible for cancer growth, chemoresistance and metastasis. The spectral information from FTIRM was correlated with the outcomes of cytotoxicity tests and image-based cytometry, and specific spectral signatures attributable to 5-azacytidine treatment were identified, allowing us to hypothesise the demethylation of DNA and, hence, an increase in the transcriptional activity, together with a conformational transition of DNA, and a triggering of cell death by an apoptosis mechanism. Moreover, a different mechanism of action between OSSC and CSC cells was highlighted, probably due to possible differences between OSCCs and CSCs response.

Identifiants

pubmed: 34440896
pii: cells10082127
doi: 10.3390/cells10082127
pmc: PMC8392608
pii:
doi:

Substances chimiques

Azacitidine M801H13NRU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nucleic Acids Res. 2011 Jul;39(13):5439-48
pubmed: 21447564
Biophys Chem. 2010 Nov;152(1-3):164-9
pubmed: 20970241
Nat Protoc. 2014 Aug;9(8):1771-91
pubmed: 24992094
Int J Cancer. 2008 Jul 1;123(1):8-13
pubmed: 18425818
Cancer Cell. 2012 May 15;21(5):655-667
pubmed: 22624715
Trends Biotechnol. 2006 Oct;24(10):455-62
pubmed: 16935373
Biophys Chem. 2003 Jun 1;104(2):477-88
pubmed: 12878315
J Biol Chem. 1996 May 17;271(20):11595-8
pubmed: 8662853
Cell Physiol Biochem. 2015;36(2):784-98
pubmed: 26021266
Anal Chem. 2016 Dec 20;88(24):12090-12098
pubmed: 28193045
Mol Hum Reprod. 2018 Nov 1;24(11):521-532
pubmed: 30124927
Nat Protoc. 2016 Apr;11(4):664-87
pubmed: 26963630
Sci Rep. 2019 Dec 3;9(1):18236
pubmed: 31796828
Crit Rev Oncog. 2018;23(3-4):189-200
pubmed: 30311574
Biochem J. 1999 May 15;340 ( Pt 1):51-8
pubmed: 10229658
Biopolymers. 2002;67(6):470-86
pubmed: 12209454
Biochim Biophys Acta. 2016 Jan;1864(1):85-101
pubmed: 26327318
Anal Chem. 2014 Dec 16;86(24):12047-54
pubmed: 25415602
Chem Soc Rev. 2016 Apr 7;45(7):1980-98
pubmed: 26403652
PLoS One. 2012;7(4):e35558
pubmed: 22530050
Clin Epigenetics. 2019 Aug 12;11(1):116
pubmed: 31405379
Anal Chem. 2012 Jun 5;84(11):4768-75
pubmed: 22524189
Cell Commun Signal. 2017 Mar 29;15(1):12
pubmed: 28356110
Spectrochim Acta A Mol Biomol Spectrosc. 2019 Apr 5;212:206-214
pubmed: 30639914
Mol Cancer Ther. 2007 Jun;6(6):1718-27
pubmed: 17575103
Food Funct. 2014 Aug;5(8):1939-48
pubmed: 24956972
PLoS One. 2011;6(8):e23452
pubmed: 21853135
J Appl Oral Sci. 2017 Nov-Dec;25(6):708-715
pubmed: 29211293
Clin Epigenetics. 2015 Sep 11;7:98
pubmed: 26366235
PLoS One. 2017 Jan 23;12(1):e0170740
pubmed: 28114349
Lancet. 2008 May 17;371(9625):1695-709
pubmed: 18486742
Int J Cancer. 2014 Mar 15;134(6):1270-8
pubmed: 24105655
Oncogene. 2002 Aug 12;21(35):5483-95
pubmed: 12154409
Analyst. 2012 Jan 21;137(2):322-32
pubmed: 22114757
Analyst. 2018 Jul 9;143(14):3317-3326
pubmed: 29931010
Immunol Rev. 2001 Dec;184:286-98
pubmed: 12086319
Sci Rep. 2017 Jun 1;7(1):2649
pubmed: 28572622
Leuk Lymphoma. 2003 Nov;44(11):1957-62
pubmed: 14738150
Head Neck. 2010 Mar;32(3):357-67
pubmed: 19644932
Int J Mol Sci. 2020 Sep 27;21(19):
pubmed: 32992491
Cancer Lett. 2010 Mar 28;289(2):151-60
pubmed: 19748175
J Exp Clin Cancer Res. 2017 Nov 23;36(1):164
pubmed: 29169370
Analyst. 2021 Jan 7;145(24):8038-8049
pubmed: 33063801
Mol Cancer. 2017 Feb 1;16(1):29
pubmed: 28148257
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 May;127(5):425-432
pubmed: 30827853
Fertil Steril. 2014 Jan;101(1):120-7
pubmed: 24140036
PLoS One. 2014 Jan 08;9(1):e84880
pubmed: 24416304
Analyst. 2014 Jun 21;139(12):3097-106
pubmed: 24781500
J Biophotonics. 2020 Apr;13(4):e201960071
pubmed: 31648419
Int J Mol Sci. 2017 Jul 12;18(7):
pubmed: 28704968
Chin J Cancer. 2013 Nov;32(11):614-8
pubmed: 23601241
Eur J Surg Oncol. 2018 May;44(5):559-565
pubmed: 29433990
Sci Rep. 2016 Nov 14;6:37017
pubmed: 27841324

Auteurs

Valentina Notarstefano (V)

Department of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.

Alessia Belloni (A)

Department of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.

Simona Sabbatini (S)

Department of Material, Environmental Sciences and Urban Planning, Università Politecnica Delle Marche, 60131 Ancona, Italy.

Chiara Pro (C)

Department of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.

Giulia Orilisi (G)

Department of Clinical Sciences and Stomatology, Università Politecnica Delle Marche, 60126 Ancona, Italy.

Riccardo Monterubbianesi (R)

Department of Clinical Sciences and Stomatology, Università Politecnica Delle Marche, 60126 Ancona, Italy.

Vincenzo Tosco (V)

Department of Clinical Sciences and Stomatology, Università Politecnica Delle Marche, 60126 Ancona, Italy.

Hugh J Byrne (HJ)

FOCAS Research Institute, Technological University Dublin, Dublin 8, Ireland.

Lisa Vaccari (L)

Elettra Sincrotrone Trieste, SISSI Beamline, 34149 Basovizza, Italy.

Elisabetta Giorgini (E)

Department of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH